Drug intelligence / Profile preview

ethanol + aspirin

Development stage
Discontinued
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral
01

Overview

Ethanol + aspirin is a non-standard combination of two widely used substances—ethanol (alcohol) and aspirin (acetylsalicylic acid). Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that works by irreversibly inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to reduced synthesis of prostaglandins and thromboxanes, which mediate pain, inflammation, fever, and platelet aggregation[7][2]. Ethanol is a central nervous system depressant with multiple mechanisms of action including potentiation of GABA-A receptor activity and inhibition of NMDA receptors. The co-administration or concurrent use of ethanol with aspirin is not recommended due to increased risk for gastrointestinal irritation, ulcers, bleeding, nausea, vomiting, heartburn, or stomach upset[5][4][1]. Ethanol can enhance the absorption of aspirin from the gastrointestinal tract but does not affect its metabolism; this may increase plasma concentrations of salicylic acid—the active metabolite—and exacerbate acute toxicity[6]. There are no approved pharmaceutical products combining these two agents.

Other names
ethanol and aspirinalcohol and acetylsalicylic acid
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ethanol + aspirin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethanol + aspirin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call